DNA repair in tumor radioresistance: insights from fruit flies genetics
- PMID: 38095764
- DOI: 10.1007/s13402-023-00906-6
DNA repair in tumor radioresistance: insights from fruit flies genetics
Abstract
Background: Radiation therapy (RT) is a key anti-cancer treatment that involves using ionizing radiation to kill tumor cells. However, this therapy can lead to short- and long-term adverse effects due to radiation exposure of surrounding normal tissue. The type of DNA damage inflicted by radiation therapy determines its effectiveness. High levels of genotoxic damage can lead to cell cycle arrest, senescence, and cell death, but many tumors can cope with this damage by activating protective mechanisms. Intrinsic and acquired radioresistance are major causes of tumor recurrence, and understanding these mechanisms is crucial for cancer therapy. The mechanisms behind radioresistance involve processes like hypoxia response, cell proliferation, DNA repair, apoptosis inhibition, and autophagy.
Conclusion: Here we briefly review the role of genetic and epigenetic factors involved in the modulation of DNA repair and DNA damage response that promote radioresistance. In addition, leveraging our recent results on the effects of low dose rate (LDR) of ionizing radiation on Drosophila melanogaster we discuss how this model organism can be instrumental in the identification of conserved factors involved in the tumor resistance to RT.
Keywords: DNA repair; Drosophila; Radiobiology; Radioresistance; Radiotherapy.
© 2023. Springer Nature Switzerland AG.
Similar articles
-
Lysosomes contribute to radioresistance in cancer.Cancer Lett. 2018 Dec 28;439:39-46. doi: 10.1016/j.canlet.2018.08.029. Epub 2018 Sep 11. Cancer Lett. 2018. PMID: 30217567 Review.
-
Evidences of radioresistance in Drosophila melanogaster from Northeastern Brazil.Int J Radiat Biol. 2025;101(2):164-173. doi: 10.1080/09553002.2024.2440858. Epub 2024 Dec 17. Int J Radiat Biol. 2025. PMID: 39689110
-
Autophagy and its function in radiosensitivity.Tumour Biol. 2015 Jun;36(6):4079-87. doi: 10.1007/s13277-015-3496-x. Epub 2015 May 7. Tumour Biol. 2015. PMID: 25946972 Review.
-
Radio-miRs: a comprehensive view of radioresistance-related microRNAs.Genetics. 2024 Aug 7;227(4):iyae097. doi: 10.1093/genetics/iyae097. Genetics. 2024. PMID: 38963803 Free PMC article. Review.
-
DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair.Mol Med Rep. 2015 Jul;12(1):1328-34. doi: 10.3892/mmr.2015.3505. Epub 2015 Mar 18. Mol Med Rep. 2015. PMID: 25815686
Cited by
-
A nomogram with Nottingham prognostic index for predicting locoregional recurrence in breast cancer patients.Front Oncol. 2024 Sep 16;14:1398922. doi: 10.3389/fonc.2024.1398922. eCollection 2024. Front Oncol. 2024. PMID: 39351357 Free PMC article.
-
Transcription Impairment of TMEM208 by ZBTB14 Suppresses Breast cancer Radiotherapy Resistance.J Mammary Gland Biol Neoplasia. 2024 Dec 18;29(1):20. doi: 10.1007/s10911-024-09573-1. J Mammary Gland Biol Neoplasia. 2024. PMID: 39692812 Free PMC article.
-
Molecule interacting with CasL-2 enhances tumor progression and alters radiosensitivity in cervical cancer.J Transl Med. 2025 Jan 11;23(1):44. doi: 10.1186/s12967-024-06065-y. J Transl Med. 2025. PMID: 39799334 Free PMC article.
-
Nuclear receptors as novel regulators that modulate cancer radiosensitivity and normal tissue radiotoxicity.Mol Cancer. 2025 May 30;24(1):155. doi: 10.1186/s12943-025-02362-2. Mol Cancer. 2025. PMID: 40442680 Free PMC article. Review.
-
DROSOPHILA: THE CENTURY-LONG FLIGHT FROM THE WILD TO THE PATIENT.Med Sci Pulse. 2025 Mar 30;19(1):1-15. doi: 10.5604/01.3001.0054.9627. Epub 2025 Feb 5. Med Sci Pulse. 2025. PMID: 40276781 Free PMC article.
References
-
- E. Abad, D. Graifer, A. Lyakhovich, Cancer Lett. 474, 106–117 (2020). https://doi.org/10.1016/j.canlet.2020.01.008 - DOI - PubMed
-
- M. Baumann, M. Krause, R. Hill, Nat. Rev. Cancer 8, 545–554 (2008). https://doi.org/10.1038/nrc2419 - DOI - PubMed
-
- R. Mohan, D. Grosshans, Adv. Drug Deliv. Rev. 109, 26–44 (2017). https://doi.org/10.1016/j.addr.2016.11.006 - DOI - PubMed
-
- D. Schaue, W.H. McBride, Nat. Rev. Clin. Oncol. 12, 527–540 (2015). https://doi.org/10.1038/nrclinonc.2015.120 - DOI - PubMed - PMC
-
- R.A. Chandra, F.K. Keane, F.E.M. Voncken, C.R. Thomas Jr., Lancet 398, 171–184 (2021). https://doi.org/10.1016/S0140-6736(21)00233-6 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases